Merit Medical Systems | MMSI - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
3M USD 1.06B 317M 2026-06
Abbott USD 3.6B 330M 2026-06
AngioDynamics USD 36.57M 3.79M 2025-09
Anika Therapeutics USD 10.01M 14K 2025-12
AtriCure USD 84.55M 6.21M 2026-03
Baxter International USD 728M 33M 2026-03
Becton, Dickinson and Co. USD 1.21B 180M 2026-03
Boston Scientific USD 1.78B 53M 2026-03
Cooper Companies USD 676.2M 303.1M 2026-03
Dexcom USD 349.7M 49.8M 2026-03
Edwards Lifesciences USD 522.2M 80.7M 2026-03
Globus Medical USD 297.77M 20.7M 2026-03
Haemonetics USD 109.15M 7.54M 2025-12
ICU Medical USD 155.81M 3.04M 2025-12
Insulet USD 317.2M 14.2M 2026-03
Integra LifeSciences USD 178.24M 21.79M 2026-03
J&J USD 6.42B 381M 2026-06
Medtronic 2.96B 9M 2025-12
Merit Medical Systems USD 110.47M 4.36M 2026-03
Olympus JPY 139.34B 13.69B 2026-03
Pfizer USD 2.92B 1.16B 2026-03
STAAR Surgical USD 38.64M 299K 2026-03
Stryker USD 2.15B 17M 2026-03
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 226.01M 3.64M 2026-03
Terumo JPY 114.81B 9.55B 2026-03
Zimmer Biomet Holdings USD 849.9M 5.8M 2026-03